ADAMI, Silvano
 Distribuzione geografica
Continente #
NA - Nord America 33.032
EU - Europa 25.191
AS - Asia 16.647
SA - Sud America 1.987
AF - Africa 367
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 11
Totale 77.264
Nazione #
US - Stati Uniti d'America 32.770
GB - Regno Unito 8.805
SG - Singapore 7.464
RU - Federazione Russa 6.744
CN - Cina 4.713
DE - Germania 1.677
IT - Italia 1.665
BR - Brasile 1.621
FR - Francia 1.479
SE - Svezia 1.419
VN - Vietnam 1.356
HK - Hong Kong 1.339
FI - Finlandia 1.254
IE - Irlanda 1.099
KR - Corea 577
UA - Ucraina 540
TR - Turchia 258
NG - Nigeria 191
IN - India 169
JP - Giappone 163
AR - Argentina 125
CA - Canada 115
BD - Bangladesh 109
MX - Messico 93
NL - Olanda 92
IQ - Iraq 89
BE - Belgio 79
EC - Ecuador 73
ID - Indonesia 67
PL - Polonia 59
ZA - Sudafrica 57
ES - Italia 53
CL - Cile 45
AT - Austria 42
IR - Iran 37
PK - Pakistan 36
UZ - Uzbekistan 35
CO - Colombia 31
IL - Israele 31
CZ - Repubblica Ceca 28
VE - Venezuela 28
SA - Arabia Saudita 26
MA - Marocco 25
AU - Australia 23
KE - Kenya 23
PY - Paraguay 22
PE - Perù 21
EG - Egitto 20
NP - Nepal 20
PH - Filippine 20
LT - Lituania 18
AE - Emirati Arabi Uniti 14
BG - Bulgaria 14
CH - Svizzera 14
JO - Giordania 14
RO - Romania 13
TN - Tunisia 13
UY - Uruguay 12
AZ - Azerbaigian 11
DO - Repubblica Dominicana 11
MY - Malesia 11
AL - Albania 10
JM - Giamaica 10
DZ - Algeria 9
KG - Kirghizistan 9
LV - Lettonia 9
BO - Bolivia 8
HU - Ungheria 8
QA - Qatar 8
SK - Slovacchia (Repubblica Slovacca) 8
HR - Croazia 7
NO - Norvegia 7
OM - Oman 7
PS - Palestinian Territory 7
TH - Thailandia 7
TW - Taiwan 7
A2 - ???statistics.table.value.countryCode.A2??? 6
CR - Costa Rica 6
GE - Georgia 6
GR - Grecia 6
KZ - Kazakistan 6
NZ - Nuova Zelanda 6
PA - Panama 6
PT - Portogallo 6
MD - Moldavia 5
RS - Serbia 5
SN - Senegal 5
AM - Armenia 4
BA - Bosnia-Erzegovina 4
CM - Camerun 4
IS - Islanda 4
KW - Kuwait 4
LA - Repubblica Popolare Democratica del Laos 4
LB - Libano 4
SV - El Salvador 4
BB - Barbados 3
BY - Bielorussia 3
EE - Estonia 3
EU - Europa 3
GT - Guatemala 3
Totale 77.203
Città #
Dallas 8.305
Southend 7.994
Jacksonville 4.338
Singapore 4.172
Chandler 2.545
Ashburn 2.150
Woodbridge 2.089
San Jose 1.950
Moscow 1.788
Ann Arbor 1.658
Hong Kong 1.321
Houston 1.191
Dublin 1.094
The Dalles 847
Verona 719
Beijing 552
Wilmington 550
Lawrence 538
Princeton 538
Ho Chi Minh City 437
Nanjing 428
Los Angeles 398
Jinan 395
New York 348
Shenyang 339
Buffalo 313
Hanoi 300
Helsinki 239
Boardman 232
Sindelfingen 232
Hebei 222
Milan 192
Abuja 188
Tianjin 186
Changsha 165
Tokyo 144
São Paulo 139
Nanchang 135
Dong Ket 134
Santa Clara 133
Columbus 125
Zhengzhou 123
Haikou 121
Jiaxing 113
Ningbo 113
Hangzhou 112
Guangzhou 110
Taizhou 100
Redondo Beach 92
Orem 86
Munich 85
Brussels 74
Falls Church 73
Taiyuan 71
Norwalk 68
Frankfurt am Main 67
San Francisco 65
Philadelphia 62
Council Bluffs 59
Rio de Janeiro 58
Chicago 57
Detroit 57
Fairfield 56
Lanzhou 54
Warsaw 51
Amsterdam 50
Da Nang 50
Seattle 50
Chennai 49
Lancaster 47
Fuzhou 46
London 46
Bologna 43
Brooklyn 43
Dearborn 40
Phoenix 40
Rome 40
Denver 39
Washington 39
Turku 38
Atlanta 37
Belo Horizonte 37
Brasília 37
Düsseldorf 36
Haiphong 36
Paris 36
Toronto 36
Redmond 35
Falkenstein 33
Orani 33
Stockholm 31
Biên Hòa 30
Curitiba 30
Johannesburg 30
Mexico City 30
Montreal 30
Nuremberg 30
Auburn Hills 29
Manchester 29
Porto Alegre 29
Totale 53.004
Nome #
1,25-dihydroxy vitamin D in primary hyperparathyroidism 3.860
1,25 (OH) 2D3 stimulates and bisphosphonates inhibit fibronectin release by human microphages. 3.761
Teriparatide and denosumab combination therapy and skeletal metabolism 340
Artrite Reumatoide e Metabolismo Minerale 268
[The long term correction of vitamin D deficiency: comparison between different treatments with vitamin D in clinical practice.]. 265
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 259
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 251
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 251
PAEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDER ASSOCIATED WITH GROUP A STREPTOCOCCAL INFECTION (PANDAS): CARDIAC AND ARTICULAR INVOLVEMENT 249
[Incidence of thyroid diseases in primary hyperparathyroidism] 246
[Serum calcium evaluation and incidence of primary hyperparathyroidism in hospitalized patients (author's transl)] 245
25-OH-D metabolism in primary hyperparathyroidism 245
[Rational bases for the treatment of osteoporosis] 242
12 month-retrospective analysis of two different rituximab retreatment regimens in rheumatoid arthritis:retreatment at clinical relapse Vs 6 (th) month fixed retreatment 242
25-hydroxyvitamin D levels in healthy premenopausal wome: association with bone turnover markers and bone mineral density 241
The effects of menopause and estrogen replacement therapy on the renal handling of calcium 239
[Acid-base balance in primary hyperparathyroidism] 238
Association of CTR and COLIA1 alleles with BMD values in peri and postmenopausal women 237
Age-related bone loss in postmenopausal women 231
[Therapeutic strategies in osteoporosis: whom and when to treat] 229
[Diphosphonates: and alternative to estrogen therapy in postmenopausal osteoporosis. Experience with alendronate] 227
La correzione dell’ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica. 227
Trattamento dell'osteoporosi cortisonica con Nandrolone Decanoato 226
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 224
12 month-retrospective analysis of two different Rituximab pretreatment regimens in Rheumatoid Arthritis: retreatment at clinical relapse versus 6th month fixed pretreatment. 222
[Studies on the therapeutic efficacy of a new diuretic combination in patients with edema of hepatic and cardiac etiology] 221
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 218
Effects of therapeutic doses of salbutamol alone and combined with beclomethasone dipropionate on airway responsiveness and cyclic AMP plasma levels in asthmatic patients 214
Il trattamento del morbo di Paget con calcitonina umana: influenza della secrezione paratoidea e dei titoli di anticorpi anti-calcitonina (umana e porcina) 214
[Risk factors for hip fracture in elderly persons]. 214
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 212
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 210
[Comparative studies of the behavior of blood calcium and urinary hydroxyproline after infusion of calcitonin and glucagon in patients with Paget's disease] 209
Effects of nandrolone decanoate (Decadurabolin) on serum Lp(a), lipids and lipoproteins in women with postmenopausal osteoporosis 209
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 209
Analisi di linkage di geni candidati per densità minerale 207
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 206
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 203
[Study of vitamin D status of rheumatoid arthritis patients. Rationale and design of a cross-sectional study by the osteoporosis and metabolic bone diseases study group of the Italian Society of Rheumatology (SIR)]. 202
Bone involvement and osteoporosis in mastocytosis. 200
Incidenza di ipovitaminosi D nel Nord Italia 197
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 197
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 196
Aberration in vitamin D metabolism during mianserin treatment [letter] 193
Fasting serum gastrin in primary hyperparathyroidism and in chronic hypercalcemia 192
Power Doppler ultrasonographic findings in healthy pediatric entheses 192
Prevalence and incidence of rheumatoid arthritis in Italy. 187
Serum thyroid hormone concentrations and weight loss relationships in eight obese women during semistarvation 186
[Italian guidelines for the diagnosis and treatment of Paget's disease of bone]. 186
Bone involvement in patient with clonal mast cell disorders 186
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 186
Primary hyperparathyroidism: diagnostic value of a model of multivariate statistical analysis 185
Antinuclear antibody profile in systemic sdclerosis patients who are negative for anticentromere and anti-topoisomerase I specificities 184
L'attività xantino-ossidasica epatocitaria nelle siderocromatosi primitive e secondarie 184
Growth Hormone in Combination with Bisphosphonate Treatment in Osteogenesis Imperfecta. 184
Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease 184
Association between bone mineral density and serum lipid in men 183
Valutazione ecografia con power doppler delle entesi in età pediatrica 183
[Pathophysiology of osteoarthritis: perspectives] 183
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 183
Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone 182
[Ketotifen in the therapy of bronchial asthma] 181
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 181
[Antinflammatory therapy and cardiovascular risk: a consensus view]. 180
Response of Paget's disease to human calcitonin in patients resistant to porcine calcitonin 178
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 176
Allergy and the bone: unexpected relationships 176
Sustained vertebral fracture risk reduction after withdrowal of teriparatide in postmenopausal women with osteoporosis 175
[Use of nonsteroidal anti-inflammatory drugs in patients with vertebral osteoporotic fractures]. 175
Adherence to therapeutic and diagnostic recommendations in patients with femur fracture and at risk of re-fracture or death: results of an analysis of administrative databases. 174
Discriminant analysis in the differential diagnosis of hypercalcaemia 172
Rapporti tra sistema immune e metabolismo osseo 172
Osteoporosis treatment: why ibandronic acid? 172
Adverse effects of bisphosphonates. A comparative review 171
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 171
Clinical utility of a wheat-germ precipitation assay for determination of bone alkaline phosphatase concentrations in patients with different metabolic bone diseases 170
[Diacetylrhein in the treatment of degenerative arthropathies] 170
Digital Amputation in Systemic Sclerosis: Prevalence and Clinical Associations. A Retrospective Longitudinal Study. 169
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 169
ARTROPATIE DISMETABOLICHE 168
DXA bone mineral density in males: retrospective study in real life. 166
Bone mineral metabolism in girls with precocious puberty during gonadotrophin-releasing hormone agonist treatment 166
Simultaneous measurement of 1.25-dihydroxy-vitamin D, 24.25-dihydroxy-vitamin D and 25-hydroxy-vitamin D from a single two milliliters serum specimen. Preliminary clinical application 166
Il dosaggio del calcio ionizzato nelle alterazioni del metabolismo fosfo-calcico 166
Valore del dosaggio radioimmunologico del paratormone plasmatico nella diagnosi di iperparatiroidismo primitivo 166
Calcio e derivati della vitamina D, terapia sostitutiva, calcitonina, fluoruri, bisfosfonati 166
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 166
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 165
Acute effects of deflazacort and prednisone on rates of mineralization and bone formation 164
[Relations between polycystic ovary and idiopathic hirsutism] 163
Circdian rhytm in serum PTH concentration in normal subjects and in primary hyperparathyroidoism: correlation with ionized serum calcium 163
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 163
A morphometric ultrastructural study of unenvolved parathyroid glands in primary iperparathyroidism 163
Contributo allo studio del meccanismo d'azione ipouricemizzante del benziodarone 162
Regulation of calcium-parathyroid hormone feedback in primary hyperparathyroidism: effects of bisphosphonate treatment 162
Effect of hyperandrogenism and menstrual cycle abnormalities on bone mass and bone turnover in young women 161
The ultrastructure of bone cells and bone matrix in human primary hyperparathyroidism 161
Effects of denosumab on peripheral lymphocyte subpopulations 160
Substrate-product relation of 1-hydroxylase activity in primary hyperparathyroidism 159
Spie metaboliche precoci delle alterazioni ossee nell'iperparatiroidismo primitivo 159
Totale 26.913
Categoria #
all - tutte 217.621
article - articoli 203.036
book - libri 0
conference - conferenze 7.279
curatela - curatele 0
other - altro 1.280
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.026
Totale 435.242


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021886 0 0 0 0 0 0 0 0 0 24 594 268
2021/20223.752 253 936 33 133 263 217 41 235 177 122 437 905
2022/20237.853 704 527 979 1.243 763 1.861 63 512 786 57 250 108
2023/20243.300 204 293 303 497 449 386 120 257 34 108 407 242
2024/20259.062 678 794 349 1.403 418 160 361 529 1.313 617 540 1.900
2025/202628.651 1.937 3.070 6.547 3.389 5.015 1.893 2.645 1.317 1.863 975 0 0
Totale 77.553